Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision oncology in cholangiocarcinoma integrates molecular taxonomy testing strategies and treatment sequencing.

Discover oncology·2026
Same author

Laparoscopic removal of retrievable inferior vena cava filters after failed or anticipated technically challenging endovascular retrieval: a retrospective case series of 28 patients.

Frontiers in physiology·2026
Same author

Cross-cohort multi-omics analysis identifies novel clusters driven by epithelial-mesenchymal transition signatures in gastric cancer.

Cancer cell international·2026
Same author

The Impact of Prehabilitation on Postoperative Outcomes in Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.

Journal of the American Medical Directors Association·2026
Same author

Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention Strategies.

Biomedicines·2025
Same author

Clinical diagnosis and treatment of transdiaphragmatic intercostal hernia: a retrospective study based on 40 cases.

Frontiers in surgery·2025

Related Experiment Video

Updated: Sep 10, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.9K

Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and Perspectives.

Xiaodong Xun1,2, Jialing Hao3,4, Qian Cheng3,4

  • 1Department of General Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100035, China.

Biomedicines
|August 28, 2025
PubMed
Summary

Induced pluripotent stem cells (iPSCs) are revolutionizing cancer treatment by generating engineered immune cells for personalized therapy. Research focuses on enhancing targeting, efficacy, and safety for improved outcomes in oncology.

Keywords:
cancercellular immunotherapyimmunocytesinduced pluripotent stem cells

More Related Videos

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.5K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Related Experiment Videos

Last Updated: Sep 10, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.9K
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.5K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Area of Science:

  • Oncology
  • Immunology
  • Stem Cell Biology

Background:

  • Cellular immunotherapy represents a paradigm shift in cancer treatment.
  • Induced pluripotent stem cells (iPSCs) offer a source for generating patient-specific immune cells.
  • iPSCs-derived immunocytes hold promise for personalized cancer therapy with reduced immune rejection.

Purpose of the Study:

  • To review the advancements in generating iPSCs-derived immunocytes for cancer therapy.
  • To highlight novel techniques for iPSC-derived immunocyte induction and amplification.
  • To discuss the challenges and future directions in iPSC-based cellular immunotherapy.

Main Methods:

  • Generation of various immunocytes (T cells, NK cells, macrophages, etc.) from iPSCs.
  • Application of small-molecule techniques, 3D culture systems, and nanotechnology for cell induction and amplification.
  • Utilizing animal models for in vivo amplification studies.

Main Results:

  • Successful generation of diverse iPSCs-derived immunocytes.
  • Development of innovative methods for cell induction and in vivo amplification.
  • Identification of key challenges including targeting efficiency, biological activity, and safety.

Conclusions:

  • iPSCs-derived immunocytes offer a promising avenue for personalized oncology.
  • Further research is needed to optimize cell characteristics and overcome tumor microenvironment challenges.
  • Ongoing clinical trials and combination therapies are exploring the full therapeutic potential.